Effects of cleavage by a disintegrin and metalloproteinase with thrombospondin motifs-4 on gene expression and protein content of versican and aggrecan in the digital laminae of horses with starch gruel-induced laminitis

American Journal of Veterinary Research

Volumn 73, Issue 7, 2012, Pages 1047-1056

  Wang, Le ^a   Pawlak, Erica ^a   Johnson, Philip J ^b   Belknap, James K ^c   Alfandari, Dominique ^a   Black, Samuel J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AGGRECANASE 1; COMPLEMENTARY DNA; STARCH; VERSICAN;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM BASAL CELL; FEVER; FOOT DISEASE; FORELIMB; GENE EXPRESSION; HOOF AND CLAW; HORSE; IMMUNOFLUORESCENCE TEST; LAMINITIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAM PROTEINS; AGGRECANS; ANIMALS; BLOTTING, WESTERN; ENZYME ACTIVATION; FOOT DISEASES; GENE EXPRESSION PROFILING; HOOF AND CLAW; HORSE DISEASES; HORSES; PROCOLLAGEN N-ENDOPEPTIDASE; REAL-TIME POLYMERASE CHAIN REACTION; RNA; STATISTICS, NONPARAMETRIC; VERSICANS;

EQUIDAE;

EID: 84863422362     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.7.1047     Document Type: Article

References (44)

1. Pollitt C. The anatomy and physiology of the suspensory apparatus of the distal phalanx. Vet Clin North Am Equine Pract 2010;26:29-49.
2. Eades SC. Overview of what we know about the pathophysiology of laminitis. J Equine Vet Sci 2010;30:83-86.
3. van Eps AW. Therapeutic hypothermia (cryotherapy) to prevent and treat acute laminitis. Vet Clin North Am Equine Pract 2010;26:125-133.
4. Faleiros RR, Stokes AM, Eades SC, et al. Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis. Am J Vet Res 2004;65:578-585.
5. French KR, Pollitt CC. Equine laminitis: congenital, hemidesmosomal plectin deficiency in a Quarter Horse foal. Equine Vet J 2004;36:299-303.
6. French KR, Pollitt CC. Equine laminitis: loss of hemidesmosomes in hoof secondary epidermal lamellae correlates to dose in an oligofructose induction model: an ultrastructural study. Equine Vet J 2004;36:230-235.
7. Loftus JP, Johnson PJ, Belknap JK, et al. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopathol 2009;129:221-230.
8. Faleiros RR, Johnson PJ, Nuovo GJ, et al. Laminar leukocyte accumulation in horses with carbohydrate overload-induced laminitis. J Vet Intern Med 2011;25:107-115.
9. Loftus JP, Belknap JK, Black SJ. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophils abundance. Vet Immunol Immunopathol 2006;113:267-276.
10. Mungall BA, Pollitt CC. Zymographic analysis of equine laminitis. Histochem Cell Biol 1999;112:467-472.
11. Okamoto T, Akaike T, Sawa T, et al. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 2001;276:29596-29602.
12. Bannikov GA, Karelina TV, Collier IE, et al. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 2002;277:16022-16027.
13. Yin C, Pettigrew A, Loftus JP, et al. Tissue concentrations of 4-HNE in the black walnut extract model of laminitis: indication of oxidant stress in affected laminae. Vet Immunol Immunopathol 2009;129:211-215.
14. Coyne MJ, Cousin H, Loftus JP, et al. Cloning and expression of ADAM-related metalloproteases in equine laminitis. Vet Immunol Immunopathol 2009;129:231-241.
15. Pawlak E, Wang L, Johnson PJ, et al. Distribution and processing of a disintegrin and metalloproteinase with thrombospondin motifs-4, aggrecan, versican, and hyaluronan in equine digital laminae. Am J Vet Res 2012;73:1035-1046.
16. Roughley PJ, Melching LI, Heathfield TF, et al. The structure and degradation of aggrecan in human intervertebral disc. Eur Spine J 2006;15(suppl 3):S326-S332.
17. Ricciardelli C, Sakko AJ, Ween MP, et al. The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev 2009;28:233-245.
18. Salter RC, Ashlin TG, Kwan AP, et al. ADAMTS proteases: key roles in atherosclerosis? J Mol Med 2010;88:1203-1211.
19. Kiani C, Chen L, Wu YJ, et al. Structure and function of aggrecan. Cell Res 2002;12:19-32.
20. Miwa HE, Gerken TA, Huynh TD, et al. Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. Biochim Biophys Acta 2006;1760:472-486.
21. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002;14:617-623.
22. Sheng W, Wang G, La Pierre DP, et al. Versican mediates mesenchymal-epithelial transition. Mol Biol Cell 2006;17:2009-2020.
23. Garner HE, Coffman JR, Hahn AW, et al. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 1975;36:441-444.
24. Johnson PJ, Kreeger JM, Keeler M, et al. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis. Equine Vet J 2000;32:462-468.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 2001;25:402-408.
26. Tortorella MD, Arner EC, Hills R, et al. ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch Biochem Biophys 2005;444:34-44.
27. Sandy JD, Neame PJ, Boynton RE, et al. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 1991;266:8683-8685.
28. Sandy JD, Westling J, Kenagy RD, et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 2001;276:13372-13378.
29. Westling J, Gottschall PE, Thompson VP, et al. ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein. Biochem J 2004;377:787-795.
30. Pollitt CC, Visser MB. Carbohydrate alimentary overload lamintis. Vet Clin North Am Equine Pract 2010;26:65-78.
31. Stamenkovic V, Keller G, Nesic D, et al. Neocartilage formation in 1g, stimulated, and microgravity environments: implication for tissue engineering. Tissue Eng Part A 2010;16:1729-1736.
32. Corps AN, Robinson AH, Movin T, et al. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) 2006;45:291-294.
33. Ley C, Svala E, Nilton A, et al. Effects of high mobility group box protein-1, interleukin-1β, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte cultures. Connect Tissue Res 2011;52:290-300.
34. Kahari VM, Larjava H, Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-β1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem 1991;266:10608-10615.
35. Kamitani S, Yamauchi Y, Kawasaki S, et al. Simultaneous stimulation with TGF-β1 and TNF-B1; induces epithelial mesenchymal transition in bronchial epithelial cells. Int Arch Allergy Immunol 2010;155:119-128.
36. Corps AN, Jones GC, Harrall RL, et al. The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol 2008;27:393-401.
37. Cross NA, Chandrasekharan S, Jokonya N, et al. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15 and TIMP-3 by TGF-β1 in prostate cells: relevance to the accumulation of versican. Prostate 2005;63:269-275.
38. Flannery CR, Zeng W, Corcoran C, et al. Autocatalytic cleavage of ADAMTS-4 (aggrecanase-1) reveals multiple glycosaminoglycan-binding sites. J Biol Chem 2002;277:42775-42780.
39. Kashiwagi M, Enghild JJ, Gendron C, et al. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 2004;279:10109-10119.
40. Gendron C, Kashiwagi M, Lim NH, et al. Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem 2007;282:18294-18306.
41. Porter S, Clark IM, Kevorkian L, et al. The ADAMTS metalloproteinases. Biochem J 2005;386:15-27.
42. Kenagy RD, Plaas AH, Wight TN. Versican degradation and vascular disease. Trends Cardiovasc Med 2006;16:209-215.
43. Sheng W, Dong H, Lee DY, et al. Versican modulates gap junction intercellular communication. J Cell Physiol 2007;211:213-219.
44. Sheng W, Wang G, Wang Y, et al. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell 2005;16:1330-1340.